Angela R. Solano

Buenos Aires, C, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal: Journal of medical genetics

Published: January 13, 2026

From Expert Judgment to Structured Guidelines: A Brief History and Bright Future of DNA Variant Interpretation.

From Expert Judgment to Structured Guidelines: A Brief History and Bright Future of DNA Variant Interpretation.

Journal: Annals of human genetics

Published: January 31, 2025

In Silico Copy Number Variation (CNVs) Bioinformatics Estimation: Dream or Nightmare?

In Silico Copy Number Variation (CNVs) Bioinformatics Estimation: Dream or Nightmare?

Journal: EJIFCC

Published: May 01, 2023

Choosing Wisely in oncology in Latin America: what SLACOM does not recommend in the care of cancer patients in Latin America: Ten essential recommendations to avoid harmful onclogy procedures in Latin America.

Choosing Wisely in oncology in Latin America: what SLACOM does not recommend in the care of cancer patients in Latin America: Ten essential recommendations to avoid harmful onclogy procedures in Latin America.

Journal: Ecancermedicalscience

Published: April 17, 2023

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: October 07, 2022

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: May 14, 2021

Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina.

Study of the Genetic Variants in BRCA1/2 and Non-BRCA Genes in a Population-Based Cohort of 2155 Breast/Ovary Cancer Patients, Including 443 Triple-Negative Breast Cancer Patients, in Argentina.

Journal: Cancers

Published: May 07, 2021

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Journal: JAMA oncology

Published: July 03, 2020

Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.

Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.

Journal: Cancer research

Published: March 31, 2020

New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.

New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.

Journal: Cellular and molecular life sciences : CMLS

Published: February 11, 2020

Sequencing technology status of BRCA1/2 testing in Latin American Countries.

Sequencing technology status of BRCA1/2 testing in Latin American Countries.

Journal: NPJ genomic medicine

Published: November 28, 2019

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Journal: Cancer research

Published: July 01, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026